Runyan Jin

发表

FDA Approval Summary: Ramucirumab for Gastric Cancer

Huanyu Chen, K. He, P. Keegan, 2015, Clinical Cancer Research.

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

K. He, P. Keegan, R. Pazdur, 2017, Clinical Cancer Research.

Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies.

A. Wolff, S. Baker, M. Rudek, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection

C. Howell, J. McHutchison, T. Dowling, 2012, The AAPS Journal.

Down-regulation of RNA Helicase II/Gu Results in the Depletion of 18 and 28 S rRNAs in Xenopus Oocyte*

B. Valdez, R. Ochs, D. Henning, 2003, Journal of Biological Chemistry.

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

C. Howell, J. McHutchison, T. Dowling, 2012, The American Journal of Gastroenterology.

Exposure-response (E-R) and case-control analyses of ramucirumab leading to recommendation for dosing optimization in patients with gastric cancer.

L. Fashoyin-Aje, P. Keegan, Hong Zhao, 2015 .

Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.

L. J. Brunner, Shirley K Lu, Runyan Jin, 2004, European journal of pharmacology.

Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer

A. Jimeno, M. Hidalgo, R. Donehower, 2016, Journal of clinical pharmacology.

FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs

Sarah E. Dorff, Amy McKee, R. Pazdur, 2016, Clinical Cancer Research.

Silencing of RNA Helicase II/Guα Inhibits Mammalian Ribosomal RNA Production*

Lester F. Lau, L. Lau, B. Valdez, 2003, Journal of Biological Chemistry.

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

K. Goldberg, R. Pazdur, M. Manning, 2019, Clinical Cancer Research.

Silencing of RNA helicase II/Gualpha inhibits mammalian ribosomal RNA production.

L. Lau, B. Valdez, Lester F Lau, 2003, The Journal of biological chemistry.

FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations

Jiang Liu, Reena Philip, K. Goldberg, 2021, Clinical Cancer Research.

Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection

C. Howell, J. McHutchison, T. Dowling, 2012, The AAPS Journal.

FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs

Amy McKee, R. Pazdur, R. Charlab, 2016, Clinical Cancer Research.

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

P. Keegan, R. Pazdur, Hong Zhao, 2017, Clinical Cancer Research.